Whytee
I agree that there are risks here, but there is a very strong likelihood that MSB will have its first approval on 2 August if not earlier. The risk/reward calculus is compelling.
It was back in March that you stated that, after doing a lot of research, you had come to the view that a conditional approval would most likely be granted, meaning that approval would be granted on condition that there would need to be another trial in adults or adults and children. I don't know whether the approval will be conditional, but I honestly can't see the FDA insisting on a further trial in young children. We will see.
Many here understand that there will need to be another trial in adults. This suits MSB longer term strategy because it will facilitate label extension into adults if successful. Approval will make the funding & recruitment for the new trial that much easier.
So, just to put all your negativity into proper context, you nonetheless believe Ryoncil will be approved for children in sraGvHD? Or has your opinion changed and, if so, why?
- Forums
- ASX - By Stock
- 2023 The Final Countdown
WhyteeI agree that there are risks here, but there is a very...
-
- There are more pages in this discussion • 2,209 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.06 |
Change
0.030(2.91%) |
Mkt cap ! $1.210B |
Open | High | Low | Value | Volume |
$1.05 | $1.09 | $1.03 | $5.796M | 5.430M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 15990 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 48632 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 15990 | 1.060 |
3 | 33766 | 1.055 |
2 | 38526 | 1.050 |
4 | 79050 | 1.045 |
3 | 54455 | 1.040 |
Price($) | Vol. | No. |
---|---|---|
1.075 | 48632 | 3 |
1.080 | 108135 | 6 |
1.085 | 103276 | 9 |
1.090 | 239204 | 9 |
1.095 | 74283 | 8 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |